Ramelteon Impurity 24
- CAS1029134-74-4
- CatalogueRS-Z393DN7
- FormulaC13H15NO
- MW201.12
IN STOCK
On this page
Product identification
| Product name | Ramelteon Impurity 24 |
|---|---|
| Catalogue No. | RS-Z393DN7 |
| CAS No. | 1029134-74-4 |
| Molecular formula | C13H15NO |
| Molecular weight | 201.12 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Ramelteon |
| Also known as | qcsrm |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-Z393DN7 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-Z393DN7 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Ramelteon
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-Z393DN7
- Request a quotation for RS-Z393DN7
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Ramelteon
All 99 further standards are listed here — every link is in the page, not loaded later.
-
(R)-Ramelteon
IN STOCKRS-I009212 -
Ramelteon
IN STOCKRS-U080239 -
Ramelteon Impurity A
IN STOCKRS-P010047 -
Ramelteon Impurity B
IN STOCKRS-R025031 -
Ramelteon Impurity G
IN STOCKRS-R025037 -
Ramelteon Impurity H
IN STOCKRS-R025029 -
Ramelteon Impurity I
IN STOCKRS-R025030 -
Ramelteon Metabolite M-II (mixture of R and S at the hydroxy position)
IN STOCKRS-D117075 -
Ramelteon Metabolite M-II-d3 (mixture of R and S at the hydroxy position)
IN STOCKRS-R025017 -
(1,2,6,7,-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile
IN STOCKRS-I013229 -
(2E)-2-(2,3-Dihydro-6-methoxy-1H-inden-1-ylidene)acetonitrile
IN STOCKRS-Z401E0P -
(2E)-2-(2,3-Dihydro-6-methoxy-1H-inden-1-ylidene)ethanamine
IN STOCKRS-P012124 -
(2Z)-2-(2,3-Dihydro-6-methoxy-1H-inden-1-ylidene)acetonitrile
IN STOCKRS-Z401IUH -
(E)-2-(6,7-Dihydro-1H-indeno[5,4-b]furan-8(2H)-ylidene)acetonitrile
IN STOCKRS-Z412NWU -
(R)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)acetonitrile
IN STOCKRS-D117040 -
(S)-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide
IN STOCKRS-Z401DCV -
(S)-N-[2-(5-Bromo-2,3-dihydro-6-hydroxy-1H-inden-1-yl)ethyl]propanamide
CUSTOM SYNTHESISRS-Z401EF7 -
(S)-N-[2-(5-Bromo-2,3-dihydro-6-methoxy-1H-inden-1-YL)ethyl]propanamide
IN STOCKRS-Z001PIY -
(S)-N-[2-[6-Allyloxy-5-bromo-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide
IN STOCKRS-P002098 -
(S)-N-[2-[7-Allyl-5-bromo-6-benzyloxy-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide
BACK ORDERRS-P002099 -
2,3-Dihydro-1H-indene-1,3-dicarboxaldehyde
IN STOCKRS-D112024 -
2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-ylethylamine
IN STOCKRS-Z412QU2 -
2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)acetic acid
IN STOCKRS-D111070 -
2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethan-1-amine hydrochloride
CUSTOM SYNTHESISRS-R025002 -
2-(2,3-dihydrobenzofuran-4-yl)ethanol
IN STOCKRS-C002166 -
4-CHLORO-6-FLUOROPYRIDO[3,4-D]PYRIMIDINE
CUSTOM SYNTHESISRS-Z402MRG -
4-Hydroxy Ramelteon
IN STOCKRS-U067059 -
8-Boc-3,8-diazabicyclo[4.2.0]octane
IN STOCKRS-Z401LAC -
N-(2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)isobutyramide
IN STOCKRS-P025327 -
N-(2-(1,6-dihydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propionamide
IN STOCKRS-I014097 -
N-(3-bromophenyl)-6-fluoropyrido[3,4-d]pyrimidin-4-amine
IN STOCKRS-Z401D2T -
rac Ramelteon-d3
IN STOCKRS-R025012 -
rac-2,3-Dihydro-6-methoxy-1H-indene-1-ethanamine
CUSTOM SYNTHESISRS-D117012 -
rac-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide
CUSTOM SYNTHESISRS-Z401DCU -
Racemic Ramelteon
IN STOCKRS-R025024 -
Ramelteon Chiral Amide Impurity
IN STOCKRS-R025011 -
Ramelteon D5
IN STOCKRS-R025058 -
Ramelteon Ene Amine Amide
IN STOCKRS-Z412T35 -
Ramelteon Impurity IV
IN STOCKRS-R025042 -
Ramelteon Imputiry 1
IN STOCKRS-I009213 -
Ramelteon Imputiry 17
IN STOCKRS-R025003 -
Ramelteon Imputiry 18
IN STOCKRS-R025010 -
Ramelteon lsobutyryl Impurity
IN STOCKRS-R025040 -
Ramelteon RC 12; 100 MG
IN STOCKRS-Z001OZX -
Ramelteon-d3
IN STOCKRS-R025057 -
Ramelteon Impurity 1 HCl
CUSTOM SYNTHESISRS-R025018 -
Ramelteon Impurity 7
IN STOCKRS-R025004 -
Ramelteon Impurity 9
IN STOCKRS-R025005 -
Ramelteon Impurity 15
IN STOCKRS-R025041 -
Ramelteon Impurity 15 (S)-(+)-Ibuprofen
BACK ORDERRS-R025016 -
Ramelteon Impurity 16
IN STOCKRS-R025045 -
Ramelteon Impurity 17
IN STOCKRS-R025034 -
Ramelteon Impurity 19
IN STOCKRS-R025047 -
Ramelteon Impurity 20
IN STOCKRS-R025033 -
Ramelteon Impurity 21
IN STOCKRS-R025022 -
Ramelteon Impurity 33
IN STOCKRS-R025044 -
Ramelteon Impurity 34
CUSTOM SYNTHESISRS-R025032 -
Ramelteon Impurity 35
IN STOCKRS-R025001 -
Ramelteon Impurity 36
IN STOCKRS-R025020 -
Ramelteon Impurity 36 Monomer
IN STOCKRS-R025009 -
Ramelteon Impurity 38
IN STOCKRS-R025013 -
Ramelteon Impurity 44
IN STOCKRS-R025006 -
Ramelteon Impurity 44
CUSTOM SYNTHESISRS-Z401FEL -
Ramelteon Impurity 48
CUSTOM SYNTHESISRS-I001677 -
Ramelteon Impurity 49
IN STOCKRS-I001ABT -
Ramelteon Impurity 53
IN STOCKRS-I001962 -
Ramelteon Impurity 93
IN STOCKRS-R025007 -
Ramelteon Impurity 94
BACK ORDERRS-R025014 -
Ramelteon Impurity 95
IN STOCKRS-R025019 -
Ramelteon Impurity 96
IN STOCKRS-R025021 -
Ramelteon Impurity 97
IN STOCKRS-R025025 -
Ramelteon Impurity 98
IN STOCKRS-R025028 -
Ramelteon Impurity 99
IN STOCKRS-R025036 -
Ramelteon Impurity 100
CUSTOM SYNTHESISRS-R025048 -
Ramelteon Impurity 101
IN STOCKRS-R025054 -
Ramelteon Impurity 106
IN STOCKRS-R025008 -
Ramelteon Impurity 107
IN STOCKRS-R025015 -
Ramelteon Impurity 108
IN STOCKRS-R025023 -
Ramelteon Impurity 109
IN STOCKRS-R025026 -
Ramelteon Impurity 110
CUSTOM SYNTHESISRS-R025027 -
Ramelteon Impurity 111
IN STOCKRS-R025035 -
Ramelteon Impurity 112
IN STOCKRS-R025038 -
Ramelteon Impurity 113
IN STOCKRS-R025039 -
Ramelteon Impurity 114
IN STOCKRS-R025043 -
Ramelteon Impurity 115
CUSTOM SYNTHESISRS-R025046 -
Ramelteon Impurity 116
IN STOCKRS-R025049 -
Ramelteon Impurity 117
IN STOCKRS-R025051 -
Ramelteon Impurity 118
IN STOCKRS-R025052 -
Ramelteon Impurity 119
IN STOCKRS-R025053 -
Ramelteon Impurity 120
IN STOCKRS-R025055 -
Ramelteon Impurity 121
IN STOCKRS-R025056 -
Ramelteon Impurity 149
IN STOCKRS-U016107
![Chemical structure of (E)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylaMine hydrochloride](/structures/w4/OCVCFFVMNWSCNO-OAZHBLANSA-N.webp?v=8)
![Chemical structure of (R)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)acetonitrile](/structures/w4/WPIVLYZNFICYFP-SNVBAGLBSA-N.webp?v=8)
![Chemical structure of (R)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethan-1-amine Hydrochloride](/structures/w4/PTRBVFJPGFTDDU-HNCPQSOCSA-N.webp?v=8)
![Chemical structure of (S)-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide](/structures/w4/BURWKXUNJOXCGV-LBPRGKRZSA-N.webp?v=8)
![Chemical structure of (S)-N-[2-(5-Bromo-2,3-dihydro-6-hydroxy-1H-inden-1-yl)ethyl]propanamide](/structures/w4/FCIPPXPPFSLFJC-VIFPVBQESA-N.webp?v=8)
![Chemical structure of (S)-N-[2-(5-Bromo-2,3-dihydro-6-methoxy-1H-inden-1-YL)ethyl]propanamide](/structures/w4/ABLCLDGSSBMYHP-JTQLQIEISA-N.webp?v=8)
![Chemical structure of (S)-N-[2-[2,3-Dihydro-6-hydroxy-7-(2-hydroxyethyl)-1H-inden-1-yl]ethyl]propanamide](/structures/w4/NHNKXHOSEOOXLP-LBPRGKRZSA-N.webp?v=8)
![Chemical structure of (S)-N-[2-[6-Allyloxy-5-bromo-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide](/structures/w4/WWFFHGDWYBLXHO-NSHDSACASA-N.webp?v=8)
![Chemical structure of (S)-N-[2-[7-Allyl-5-bromo-2,3-dihydro-6-hydroxy-1H-inden-1-yl]ethyl]propanamide](/structures/w4/SOKCOMOZGLSICY-NSHDSACASA-N.webp?v=8)
![Chemical structure of (S)-N-[2-[7-Allyl-5-bromo-6-benzyloxy-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide](/structures/w4/DVFZQAWYEJXGJV-SFHVURJKSA-N.webp?v=8)
![Chemical structure of (S)-N-[6-Benzyloxy-5-bromo-7-(2-hydroxyethyl)-2,3-dihydro-1H-inden-1-ylidene)ethyl]propanamide](/structures/w4/OQGPZULDDZFCAN-KRWDZBQOSA-N.webp?v=8)
![Chemical structure of (S,E)-4-Phenyl-3-(2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetyl)oxazolidin-2-one](/structures/w4/KGLWTOGZPHWWHW-GOSISDBHSA-N.webp?v=8)
![Chemical structure of 2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-ylethylamine](/structures/w4/BFNUHWYOQCGTCA-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)acetic acid](/structures/w4/STJFPPKIYLSEKU-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethan-1-amine hydrochloride](/structures/w4/PTRBVFJPGFTDDU-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 4-CHLORO-6-FLUOROPYRIDO[3,4-D]PYRIMIDINE](/structures/w4/MGWFUQALPUPAER-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 8-Boc-3,8-diazabicyclo[4.2.0]octane](/structures/w4/ITVHTQLHEQGQNG-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of N-(2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)isobutyramide](/structures/w4/RXLSWWMNDCRHQF-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of N-(2-(1,6-dihydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propionamide](/structures/w4/QQSNPUATYPICGA-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of N-(3-bromophenyl)-6-fluoropyrido[3,4-d]pyrimidin-4-amine](/structures/w4/KRRHOFYUUHSVEQ-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of N-[2-[(1S)-5-bromo-2,3-dihydro-6-(2-propen-1-yloxy)-1H-inden-1-yl]ethyl]propanamide](/structures/w4/RUNQVOLEGAUOFH-LBPRGKRZSA-N.webp?v=8)
![Chemical structure of rac-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide](/structures/w4/BURWKXUNJOXCGV-UHFFFAOYSA-N.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.